Characterization of Human Anti-Dengue NS1 Monoclonal Antibodies Derived from Patients Infected with DENV-2-Reference-Cited by-同舟云学术

Characterization of Human Anti-Dengue NS1 Monoclonal Antibodies Derived from Patients Infected with DENV-2

Published:2022-01-31 Issue:1 Volume:75 Page:24-30
ISSN:1344-6304
Container-title:Japanese Journal of Infectious Diseases
language:en
Short-container-title:Jpn J Infect Dis

Author:

Kowaboot Siriporn¹,Puangmanee Wilarat¹,Benjathummarak Surachet²,Boonha Khwanchit²,Chaisri Urai³,Ramasoota Pongrama¹,Pitaksajjakul Pannamthip¹

Affiliation:

1. Department of Social and Environmental Medicine, Faculty of Tropical Medicine, Mahidol University, Thailand

2. Center of Excellence for Antibody Research, Faculty of Tropical Medicine, Mahidol University, Thailand

3. Department of Tropical Pathology, Faculty of Tropical Medicine, Mahidol University, Thailand

Publisher

Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://www.jstage.jst.go.jp/article/yoken/75/1/75_JJID.2020.1071/_pdf

Reference25 articles.

1. 1. Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res. 2002;33:330-342.

2. 2. Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature. 2013;496:504-507.

3. 3. World Health Organization. Vaccines and immunization: Dengue. Available at <https://www.who.int/news-room/q-a-detail/dengue-vaccines>. Accessed January 25, 2021.

4. 4. Halstead SB. Dengue antibody-dependent enhancement: knowns and unknowns. Microbiol Spectr. 2014;2. doi: 10.1128/microbiolspec.AID-0022-2014.

5. 5. Halstead SB, Chow JS, Marchette NJ. Immunological enhancement of dengue virus replication. Nat New Biol. 1973;243:24-26.